본문 바로가기

Introduction

A global healthcare company dedicated to customer-centric values

As a leading pharmaceutical company in South Korea, we have been dedicated and committed to the development and supply of superior pharmaceutical products that contribute to the health and well-being of people around the world.

We are steadfast in our vision of continuously growing with our customers as a leading global company by providing solutions for disease prevention and developing new solutions for healthier and happier lives.

Ildong has earned the trust of our customers with our ethical drugs franchise for chronic disease and cancer therapies, antibiotics, and digestive and circulatory drugs, in addition to our well-known OTC brands such as Biovita(probiotics product) and Aronamin(multivitamin). We are on the road to reaching our vision of becoming a global total healthcare company with various new drug pipelines including Besivo(hepatitis B therapy), which is the 28th novel drug in South Korea, as well as new innovative drug pipelines and new businesses for health functional foods, medical devices, cosmetics, and beverages.

이 표는 회사 소개 목록을 나타내는 표로 회사명, 설립일, 자본금, 대표이사, 상장일, 임직원수, 주요사업으로 구성되어 있습니다.
Company Ildong Pharmaceutical Co., Ltd.
Founded 1 August 2016(Launched as Ildong Pharmaceutical Group with corporate split-off)
Capital ₩21,591,000,000
CEO Yun Paul Woongsup
Listing Date 31 August 2016 (securities listing)
Employees 1,444(26 March 2020)
Main Business Manufacture and sales of pharmaceuticals and pharmaceutical ingredients
최상단으로 바로가기